News: Year - 2014

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba –(Marketwired – December 23, 2014) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on December 19, 2014, it issued 251,392 common shares of the Corporation (“Common Shares”) in payment of $12,569.62 in interest owing on the Corporation’s…

> Read More

Press Releases
Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – December 17, 2014) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has completed the second closing of its current…

> Read More

Press Releases
Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – December 09, 2014) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has closed its previously announced private placement offering…

> Read More

Press Releases
Kane Biotech Announces Grant of Options

WINNIPEG, Manitoba –(Marketwired – November 19, 2014) – Kane Biotech Inc. (TSX-V:KNE) a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 250,000 stock…

> Read More

Press Releases
Kane Biotech Announces Amendment to Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – November 10, 2014) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) today announced an amendment to the terms of the previous announced non-brokered private placement offering of units (“Units”) of the Corporation (the “Offering”). The Corporation has…

> Read More

Press Releases
Kane Biotech Appoints Mark Nawacki to the Board of Directors

WINNIPEG, Manitoba –(Marketwired – October 08, 2014) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial biofilms announces today the appointment of Mark Nawacki to its board of directors. Mark will be…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – October 06, 2014) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) today announced the intention of the Corporation to undertake a non-brokered private placement offering (the “Offering”) of up to 20,000,000 units (“Units”) at a price of…

> Read More

Press Releases
Kane Biotech Provides Business and Patent Update

WINNIPEG, Manitoba –(Marketwired – September 23, 2014) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is providing an update to shareholders on the company’s business objectives…

> Read More

Press Releases
Health Canada approves DispersinB® for Human Use

WINNIPEG, Manitoba –(Marketwired – July 22, 2014) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce it has obtained Health Canada’s Natural Health…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba –(Marketwired – June 26, 2014) – Kane Biotech Inc. (TSX-V:KNE)(the “Corporation”) today announced that it has issued 149,517 common shares of the Corporation (“Common Shares”) at a deemed price per share of $.085 in payment of $12,708.91 in…

> Read More